Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.2 USD | +7.90% | +36.36% | +82.97% |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 16 | Oppenheimer Upgrades Avalo Therapeutics to Outperform From Perform, Price Target is $35 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+82.97% | 16.48M | |
+2.17% | 42.75B | |
+47.64% | 41.61B | |
+12.22% | 41.34B | |
-12.36% | 26.59B | |
+8.35% | 25.49B | |
-23.10% | 18.12B | |
+30.34% | 12.24B | |
-1.34% | 11.76B | |
+8.43% | 11B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Avalo Therapeutics Promotes Neil to Chief Executive, Sullivan to Finance Chief